Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Humira
Humira
The 25 Most Popular Drugs by U.S. Spending
AARP
Fri, 05/10/24 - 11:33 am
prescription spending
Ozempic
Rybelsus
Wegovy
Eliquis
Humira
Novo Nordisk
AbbVie
Teva Pharm to launch Humira biosimilar as Q1 profit misses estimates
Reuters
Wed, 05/8/24 - 10:58 pm
Teva Pharmaceutical
earnings
biosimilars
AbbVie
Humira
Sandoz delivers 6% sales growth with Humira biosimilar leading the charge
Fierce Pharma
Tue, 05/7/24 - 06:30 pm
Sandoz
earnings
biosimilars
AbbVie
Humira
CVS Caremark’s Policy Shift On Humira Biosimilars May Not Be What The Doctor Ordered
Forbes
Thu, 05/2/24 - 11:34 am
CVS Caremark
AbbVie
Humira
biosimilars
Hyrimoz
Sandoz
PBMs
Drugmaker AbbVie expects Humira volume erosion to worsen
Reuters
Sun, 04/28/24 - 11:18 pm
AbbVie
Humira
PBMs
biosimilars
Cigna’s Evernorth to Offer Humira Biosimilar with No Out-of-Pocket Cost
BioSpace
Fri, 04/26/24 - 11:09 am
Cigna
Evernorth Health
Accredo
AbbVie
Humira
biosimilars
Alvotech, Teva Enlist New Partner to Expand Access to Humira Biosimilar in US
BioSpace
Fri, 04/19/24 - 11:28 am
Alvotech
Teva Pharmaceutical
Humira
AbbVie
Simlandi
biosimilars
Humira biosimilar scripts take off
Axios
Tue, 04/16/24 - 07:42 am
AbbVie
Humira
biosimilars
CVS Health
AbbVie’s Humira Loses Only 4% of Market Share to Biosimilars: Report
BioSpace
Tue, 04/9/24 - 11:15 am
AbbVie
Humira
biosimilars
Boehringer to lay off salespeople as Humira biosimilar sales lag
Reuters
Fri, 04/5/24 - 11:33 am
Boehringer Ingelheim
AbbVie
Humira
biosimilars
layoffs
After long road to approval, Teva and Alvotech believe their Humira biosimilar Simlandi may have an edge
Fierce Pharma
Sun, 02/25/24 - 08:57 pm
Teva Pharmaceutical
Alvotech
AbbVie
Humira
biosmilars
As Humira plummets, AbbVie dials up Rinvoq and Skyrizi estimates to a combined $27B
Fierce Pharma
Fri, 02/2/24 - 11:58 am
AbbVie
earnings
Humira
Rinvoq
Skyrizi
AbbVie’s Humira Maintains Market Dominance Amid Biosimilar Launches: Report
BioSpace
Thu, 01/18/24 - 11:30 am
AbbVie
Humira
biosimilars
The Big Three PBMs’ 2024 Formulary Exclusions: Biosimilar Humira Battles, CVS Health’s Weird Strategy, and the Insulin Shakeup
Drug Channels
Tue, 01/9/24 - 09:41 am
PBMs
formularies
Caremark
Express Scripts
OptumRx
biosimilars
Humira
AbbVie
insulin
CVS to Remove AbbVie’s Humira from Reimbursement Lists, Cover Biosimilars
BioSpace
Thu, 01/4/24 - 10:18 am
CVS Caremark
CVS Health
AbbVie
Humira
biosimilars
Humira Biosimilars Not Gaining Traction Epitomizes Dysfunctional U.S. System
Forbes
Mon, 12/4/23 - 10:14 am
Humira
AbbVie
biosimilars
FDA
FDA Accepts sBLA for Interchangeability Designation for Humira biosimilars
Dermatology Times
Wed, 11/8/23 - 09:55 pm
Samsung Bioepis
Organon
FDA
AbbVie
Humira
biosimilars
AbbVie Stock Dives As Aesthetics Sales Mar Its Third-Quarter Beat And Guidance Boost
Investors Business Daily
Fri, 10/27/23 - 11:51 am
AbbVie
earnings
aesthetics
Humira
biosimilars
FDA Decision On Interchangeable Exclusivity Allows Pfizer To Rival Boehringer On Adalimumab
Generics Bulletin
Mon, 10/9/23 - 11:35 pm
Pfizer
Humira
biosimilars
adalimumab
AbbVie
interchangeability
FDA
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Fierce Pharma
Wed, 10/4/23 - 11:21 am
Boehringer Ingelheim
Cyltezo
biosimilars
Humira
drug pricing
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »